Structure and ligand‐binding modes of human serum albumin studied by UV resonance raman spectroscopy

Biospectroscopy

Volumn 1, Issue 6, 1995, Pages 375-385

  Hashimoto, Shinji ^a   Yabusaki, Takahiko ^a   Takeuchi, Hideo ^a   Harada, Issei ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84984232996     PISSN: 10754261     EISSN: 15206343     Source Type: Journal    
DOI: 10.1002/bspy.350010603     Document Type: Article

References (51)

1. Plasma protein binding of drugs—some basic and clinical aspects
2. Serum albumin
3. Molecular aspects of ligand binding to serum albumin
4. The location of drug binding sites in human serum albumin
5. The characterization of two specific drug binding sites on human serum albumin
6. Further characterization of specific drug binding sites on human serum albumin
7. Binding of drugs to human serum albumin: XI. The specificity of three binding sites as studied with albumin immobilized in microparticles
8. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands
9. Characterization of an important drug binding area on human serum albumin including the high‐affinity binding sites of warfarin and azapropazone
10. Acetylation of human serum albumin by p‐nitrophenyl acetate
11. A highly reactive tyrosine residue as part of the indole and benzodiazepine binding site of human serum albumin
12. Drug‐binding and other physico‐chemical properties of a large tryptic and a large peptic fragment of human serum albumin
13. Atomic structure and chemistry of human serum albumin
14. Thiol‐disulfide interchange reactions between serum albumin and disulfides
15. Utilization of a prism monochromator as a sharpcut bandpass filter in ultraviolet Raman spectroscopy
16. Saturation effects on ultraviolet resonance Raman intensities: Excimer/YAG laser comparison and aromatic amino acid cross‐sections
17. UV resonance Raman and excited‐state relaxation rate studies of hemoglobin
18. Raman and ultraviolet resonance Raman spectra of proteins and related compounds
19. Structure of serum albumin
20. Secondary structure determination in proteins from deep (192–223‐nm) ultraviolet Raman spectroscopy
21. UV resonance Raman excitation profiles of the aromatic amino acids
22. Ultraviolet resonance Raman study on the binding mode of enkephalin to phospholipid membranes
23. Solvent effects on aromatic chromophores and their relation to ultraviolet difference spectra of proteins
24. Hemoglobin R → T structural dynamics from simultaneous monitoring of tyrosine and tryptophan time‐resolved UV resonance Raman signals
25. Vibrational spectra and normal coordinate analysis of p‐cresol and its deuterated analogs
26. −1 region
27. The solvatochromic comparison method. I. The β‐scale of solvent hydrogen‐bond acceptor (HBA) basicities
28. The solvatochromic comparison method. 3. Hydrogen bonding by some 2‐nitroaniline derivatives
29. −1 in the Raman spectra of tyrosyl residues in proteins and certain model compounds
30. −1 in the Raman spectra of tryptophan and related compounds
31. Ultraviolet resonance Raman spectra of bacteriorhodopsin in the light‐adapted and darkadapted states
32. Ultraviolet resonance Raman study on purple and blue membranes of Halobacterium halobium
33. Exposure of tryptophanyl residues and protein dynamics
34. Phosphorescence and optically detected magnetic resonance study of the tryptophan residue in human serum albumin
35. Resonance enhancement in the ultraviolet Raman spectra of aromatic amino acids
36. Ultraviolet resonance Raman spectroscopy of X‐Proline bonds: A new marker band of hydrogen bonding at the imide CO site
37. 4‐Hydroxycoumarin/2‐hydroxychromone tautomerism: Infrared spectra of 2‐ 13C and 3‐D labeled 4‐hydroxycoumarin and its anion
38. Tryptophan Raman bands sensitive to hydrogen bonding and side‐chain conformation
39. Conformational changes in human serum albumin as revealed by hydrogen–deuterium exchange studies
40. CD‐resolved secondary structure of bovine plasma albumin in acid‐induced isomerization
41. The molecular mechanism of the neutral‐to‐base transition of human serum albumin
42. Long chain fatty acid binding to human serum albumin
43. Stabilization of human albumin by caprylate and acetyltryptophanate
44. Inhibition of peptic digestion of serum albumin by fatty acids
45. The lone tryptophan residue of human serum albumin as part of the specific warfarin binding site. Binding of dicoumarol to the warfarin, indole, and benzodiazepine binding sites
46. Optical studies of drug–protein complexes. IV. The interaction of warfarin and dicoumarol with human serum albumin
47. Direct demonstration of the highly reactive tyrosine residue of human serum albumin located in fragment 299–585
48. Binding of suprofen to human serum albumin. Role of the suprofen carboxyl group
49. Study of interaction of carprofen and its enantiomers with human serum albumin—I. Mechanism of binding studied by dialysis and spectroscopic methods
50. Characterization of a specific drug binding site of human serum albumin
51. Effects of drug bindings on esterase activity of human serum albumin. Dissociation constants of the complexes between the protein and drugs such as N‐arylanthranilic acids, coumarin derivatives and prostaglandins